Rapid Micro Biosystems Shares Rise After Samsung Biologics Partnership
05 1월 2024 - 12:21AM
Dow Jones News
By Dean Seal
Shares of Rapid Micro Biosystems rose after the company said its
Growth Direct platform has been selected by Samsung Biologics for
the automation of microbial quality control processes.
The stock was up 9% at 98 cents in recent trading. Shares were
trading at around $1.38 a year ago.
The life-sciences technology company said before the bell on
Thursday that Samsung Biologics picked the platform to help
increase efficiency and deliver more robust data integrity as well
as scalable quality control operations.
No further details about the arrangement were given.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 04, 2024 10:06 ET (15:06 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Rapid Micro Biosystems (NASDAQ:RPID)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Rapid Micro Biosystems (NASDAQ:RPID)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024